Medical Marijuana Inc. (“MJNA”) is the first publicly held company vested in the industrial hemp markets. The company comprises a diversified portfolio of products, services, technology and businesses solely focused on the production of high concentrate CBD (cannabidiol) products.
These products range from patented and proprietary based cannabinoid products, to seed and stalk or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries.
The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 85 proprietary and patented cannabinoid “delivery methods” that are more “socially and medically acceptable” than typical industry methods. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.
Medical Marijuana Inc. (OTC: MJNA) Portfolio